Spin-off news

Here you can find news from MPG spin-off companies.

Alnylam


Alnylam Announces FDA Approval of AMVUTTRA™ (vutrisiran), an RNAi Therapeutic for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults

Alnylam


Alnylam Reports Positive Topline Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy

Dewpoint Therapeutics


Dewpoint Therapeutics Granted Foundational Platform Technology Patent by US Patent Office

Alnylam


Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1

Proteros


Proteros expands oncology collaboration and license agreement with Astrazeneca